Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
59.00
+1.15 (1.99%)
May 21, 2026, 3:19 PM AST

TADAWUL:4016 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
493.25460.48394338.44302.66287.22
Revenue Growth (YoY)
18.70%16.87%16.42%11.82%5.38%-4.79%
Cost of Revenue
187.12174.71151.59134.74119.21113.47
Gross Profit
306.13285.78242.41203.7183.45173.76
Selling, General & Admin
187.42177.35150127.59113.7397.74
Other Operating Expenses
-0.130.02-0.420.090.18-0.14
Operating Expenses
188.76178.84153.12126.17114.0497.6
Operating Income
117.37106.9389.2977.5369.4176.16
Interest Expense
-3.48-3.25-3.67-5.75-4.73-1.87
Currency Exchange Gain (Loss)
0.020.02-0.04-0.470.27-
Other Non Operating Income (Expenses)
------1.08
EBT Excluding Unusual Items
113.91103.785.5871.3164.9573.22
Gain (Loss) on Sale of Investments
------2.76
Gain (Loss) on Sale of Assets
0.040.040.120.130.08-
Pretax Income
111.93103.7486.3571.4465.0270.46
Income Tax Expense
7.426.736.55.615.574.18
Net Income
104.5197.0179.8565.8359.4566.28
Net Income to Common
104.5197.0179.8565.8359.4566.28
Net Income Growth
16.28%21.49%21.30%10.72%-10.31%-8.97%
Shares Outstanding (Basic)
353535353535
Shares Outstanding (Diluted)
353535353535
EPS (Basic)
2.982.772.281.881.701.89
EPS (Diluted)
2.982.772.281.881.701.89
EPS Growth
3.76%21.49%21.30%10.72%-10.31%-8.97%
Free Cash Flow
53.3473.7421.9171.8258.9925.28
Free Cash Flow Per Share
1.522.110.632.051.690.72
Dividend Per Share
-1.3831.143---
Dividend Growth
-21.00%----
Gross Margin
62.06%62.06%61.52%60.19%60.61%60.50%
Operating Margin
23.79%23.22%22.66%22.91%22.93%26.52%
Profit Margin
21.19%21.07%20.27%19.45%19.64%23.08%
Free Cash Flow Margin
10.81%16.01%5.56%21.22%19.49%8.80%
EBITDA
130.21119.1299.0885.1476.2582.86
EBITDA Margin
26.40%25.87%25.15%25.16%25.19%28.85%
D&A For EBITDA
12.8412.199.87.616.846.7
EBIT
117.37106.9389.2977.5369.4176.16
EBIT Margin
23.79%23.22%22.66%22.91%22.93%26.52%
Effective Tax Rate
6.63%6.49%7.53%7.85%8.57%5.93%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.